The vaccines we have are good. But they could be so much better

Written by Michael V. Callahan, former Covid-19 special advisor to the assistant secretary for public health preparedness at the Department of Health and Human Services, and was incident commander for nine international highly dangerous pathogen outbreaks. He is the director of Clinical Translation at the Vaccine and Immunotherapy Center at Massachusetts General Hospital.

And by Mark C. Poznansky infectious diseases physician and director of the Vaccine and Immunotherapy Center at Massachusetts General Hospital and an associate professor at Harvard Medical School.

Overcoming vaccine hesitancy among communities of color

Dr. Dara Udo, Dr. Mark Poznansky and Dr. Jacki Hart raise the issue of vaccine hesitancy amongst people of color and vulnerable populations and discuss what lessons can be learned from the vaccine roll out during the pandemic to improve the system.

“Vaccine hesitancy, reflected in these examples, takes a myriad of angles and directions. The fears I have heard have been disproportionately voiced by my patients of color. Given past and present treatment by the scientific community, I deeply appreciate their worries and concerns. Looking back on history and addressing existing barriers, the question becomes: What lessons can we learn and what tools can we apply to improve a drastically broken system?”